SCHEMBL4730244

SCHEMBL4730244

CNC1CCC(Cc2cc(-c3cccc([S+](C)[O-])c3)ccc2OC)(NC(=O)C(F)(F)F)CC1

nearest known ligand 0.33

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
BDKRB1 P46663 3/20 0.32
CNR1 P21554 1/20 0.32
RAF1 P04049 1/20 0.31
BRAF P15056 1/20 0.31
CYP1A2 P05177 1/20 0.30
CYP2C9 P11712 1/20 0.30
CYP2C19 P33261 1/20 0.30
PPARG P37231 1/20 0.30
PPARD Q03181 1/20 0.30
PPARA Q07869 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4734506 0.92 CYP1A2 (0.32) BDKRB1CNR1CYP1A2CYP2C9CYP2C19
SCHEMBL4733117 0.87 BDKRB1 (0.35) BDKRB1CNR1
SCHEMBL4732313 0.84 KIF11 (0.38) PPARDPPARA
SCHEMBL4732770 0.84 MLYCD (0.34) BDKRB1CNR1CYP1A2CYP2C9CYP2C19
SCHEMBL4733934 0.84 CNR1 (0.33) BDKRB1CNR1CYP1A2CYP2C9CYP2C19
SCHEMBL4731912 0.82 ALDH1A1 (0.39)
SCHEMBL4731162 0.81 CYP1A2 (0.31) CYP1A2CYP2C9CYP2C19
Trifluoroacetic Acid SCHEMBL4730245 0.80 ADORA2A (0.38) PPARGPPARDPPARA
Trifluoroacetic Acid SCHEMBL4730241 0.78 HPGD (0.41) CYP1A2CYP2C19PPARGPPARDPPARA
SCHEMBL4728846 0.77 TACR1 (0.36) BDKRB1CNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8273747-B2 tert-Butyl (4-((4'-cyano-4-methoxy-biphenyl-3-ylmethyl)-amino)-cyclohexyl)-methyl-carbamate; hedgehog pathway agonists; alopecia; angiogenesis; wound healing; alzheimer's disease; inhibit aging effects on skin CURIS, INC. (US) 2012-09-25 US disclosed
US-20080193423-A1 Small organic molecule regulators of cell proliferation CURIS, INC. (US) 2008-08-14 US disclosed
US-20080194637-A1 Small organic molecule regulators of cell proliferation CURIS, INC. (US) 2008-08-14 US disclosed
US-20080182859-A1 tert-Butyl {4-[(4'-cyano-4-methoxy-biphenyl-3-ylmethyl)-amino]-cyclohexyl}-methyl-carbamate; hedgehog pathway agonists; to modulate proliferation or differentiation in a cell or tissue in vivo or vitro; alopecia; angiogenesis; wound healing; alzheimer's disease; to inhibit aging effects on skin CURIS, INC. (US) 2008-07-31 US disclosed
WO-2008057468-A1 SMALL ORGANIC MOLECULE REGULATORS OF CELL PROLIFERATION CURIS, INC. (US) 2008-05-15 WO disclosed
WO-2008057469-A1 SMALL ORGANIC MOLECULE REGULATORS OF CELL PROLIFERATION WYETH (US) 2008-05-15 WO disclosed
WO-2008057497-A2 SMALL ORGANIC MOLECULE REGULATORS OF CELL PROLIFERATION CURIS, INC. (US) 2008-05-15 WO disclosed
US-20080058521-A1 Processes for the preparation of compounds WYETH (US) 2008-03-06 US disclosed
WO-2007089669-A2 PROCESSES FOR THE PREPARATION OF COMPOUNDS WHICH MODULATE CELL PROLIFERATION WYETH (US) 2007-08-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080193423-A1 Small organic molecule regulators of cell proliferation GLI1, SHH, SMO BDKRB1 3686/4885CNR1 641/4885RAF1 1846/4885
US-20080058521-A1 Processes for the preparation of compounds MKI67, MCL1, DCX BDKRB1 3053/4885CNR1 2612/4885RAF1 1208/4885
US-20080194637-A1 Small organic molecule regulators of cell proliferation GLI1, SHH, SMO BDKRB1 3686/4885CNR1 641/4885RAF1 1846/4885
US-20080182859-A1 tert-Butyl {4-[(4'-cyano-4-methoxy-biphenyl-3-ylmethyl)-amino]-cyclohexyl}-methyl-carbamate; hedgehog pathway agonists; to modulate proliferation or differentiation in a cell or tissue in vivo or vitro; alopecia; angiogenesis; wound healing; alzheimer's disease; to inhibit aging effects on skin SHH, GLI1, SMO BDKRB1 1010/4885CNR1 217/4885RAF1 3840/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.